Gene · 4440
Papers1,911
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,911
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Molecular and Cellular Strategies of Glioblastoma and Non-Small-Cell Lung Cancer Cells Conferring Radioresistance. | Int J Mol Sci | 2022 | 36362359 | PubTator, text mining | PubMed |
| Drug Resistance in Cancers: A Free Pass for Bullying. | Cells | 2022 | 36359776 | PubTator, text mining | PubMed |
| CircRNAs in Tumor Radioresistance. | Biomolecules | 2022 | 36358938 | PubTator, text mining | PubMed |
| Proteoglycans Determine the Dynamic Landscape of EMT and Cancer Cell Stemness. | Cancers (Basel) | 2022 | 36358747 | PubTator, text mining | PubMed |
| A novel dual epigenetic approach targeting BET proteins and HDACs in Group 3 (MYC-driven) Medulloblastoma. | J Exp Clin Cancer Res | 2022 | 36357906 | PubTator, text mining | PubMed |
| Formation of Three-Dimensional Spheres Enhances the Neurogenic Potential of Stem Cells from Apical Papilla. | Bioengineering (Basel) | 2022 | 36354515 | PubTator, text mining | PubMed |
| Single-nucleus transcriptomics of IDH1- and TP53-mutant glioma stem cells displays diversified commitment on invasive cancer progenitors. | Sci Rep | 2022 | 36348001 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals different signatures of mesenchymal stromal cell pluripotent-like and multipotent populations. | iScience | 2022 | 36339265 | PubTator, text mining | PubMed |
| Heterogeneity of glioblastoma stem cells in the context of the immune microenvironment and geospatial organization. | Front Oncol | 2022 | 36338705 | PubTator, text mining | PubMed |
| Optimization of RiPCA for the Live-Cell Detection of Pre-MicroRNA-Protein Interactions. | Chembiochem | 2022 | 36322053 | PubTator, text mining | PubMed |
| Systematic analysis of circRNA biomarkers for diagnosis, prognosis and therapy in colorectal cancer. | Front Genet | 2022 | 36313458 | PubTator, text mining | PubMed |
| Interactions of host miRNAs in the flavivirus 3´UTR genome: From bioinformatics predictions to practical approaches. | Front Cell Infect Microbiol | 2022 | 36310869 | PubTator, text mining | PubMed |
| lncRNA Malat1 and miR-26 cooperate in the regulation of neuronal progenitor cell proliferation and differentiation. | RNA | 2022 | 36302652 | PubTator, text mining | PubMed |
| Emerging Roles of RNA-Binding Proteins in Inner Ear Hair Cell Development and Regeneration. | Int J Mol Sci | 2022 | 36293251 | PubTator, text mining | PubMed |
| Assessing Putative Markers of Colorectal Cancer Stem Cells: From Colonoscopy to Gene Expression Profiling. | Diagnostics (Basel) | 2022 | 36291969 | PubTator, text mining | PubMed |
| Musashi-1 and miR-147 Precursor Interaction Mediates Synergistic Oncogenicity Induced by Co-Infection of Two Avian Retroviruses. | Cells | 2022 | 36291177 | PubTator, text mining | PubMed |
| Functions of long non-coding RNA LNC11649 in non-small cell lung cancer cells as a reprocessed form of MALAT1. | Neoplasma | 2022 | 36264775 | PubTator, text mining | PubMed |
| Knockdown of Long Noncoding RNA LINC00240 Inhibits Esophageal Cancer Progression by Regulating miR-26a-5p. | Contrast Media Mol Imaging | 2022 | 36262998 | PubTator, text mining | PubMed |
| RNA binding proteins (RBPs) and their role in DNA damage and radiation response in cancer. | Adv Drug Deliv Rev | 2022 | 36252617 | PubTator, text mining | PubMed |
| Experimental and Clinical Biomarkers for Progressive Evaluation of Neuropathology and Therapeutic Interventions for Acute and Chronic Neurological Disorders. | Int J Mol Sci | 2022 | 36233034 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4440/papers?page=13